Verve Therapeutics, Inc.
VERVDelisted Jul 25, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001840574
Verve Therapeutics, Inc. was delisted on Jul 25, 2025; its insiders filed their last Form 4 on Jul 28, 2025; 176 institutions reported holding it in 13F filings for Q2 2025, worth $819.4M in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Verve Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 123
- +1 vs. Q3 2022
- Shares held
- 62.6M
- +1.96M (+3.2%) vs. Q3 2022
- Total value
- $1.21B
- −$870.1M (−41.8%) vs. Q3 2022
- New holders
- 28
- 47 more added
- Sold out
- 27
- 29 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 3 | $0 |
| Q1 2026 | 3 | $0 |
| Q4 2025 | 4 | $344.0K |
| Q3 2025 | 9 | $1.53M |
| Q2 2025 | 176 | $819.4M |
| Q1 2025 | 191 | $369.3M |
| Q4 2024 | 166 | $443.9M |
| Q3 2024 | 174 | $364.6M |
| Q2 2024 | 167 | $371.8M |
| Q1 2024 | 163 | $1.08B |
| Q4 2023 | 157 | $1.04B |
| Q3 2023 | 134 | $847.0M |
| Q2 2023 | 121 | $1.16B |
| Q1 2023 | 125 | $911.8M |
| Q4 2022 | 123 | $1.21B |
| Q3 2022 | 124 | $2.08B |
| Q2 2022 | 101 | $695.8M |
| Q1 2022 | 92 | $1.06B |
| Q4 2021 | 96 | $1.66B |
| Q3 2021 | 73 | $1.81B |
| Q2 2021 | 69 | $2.25B |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Verve Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rock Springs Capital Management LP | 558,837 | $10.8M | 0.26% | 00.0% | Unchanged |
| BVF Inc | 650,000 | $12.6M | 0.53% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 690,000 | $13.4M | 0.03% | +150,000+27.8% | Added |
| MPM Oncology Impact Management LP | 808,661 | $15.6M | 4.06% | +172,869+27.2% | Added |
| Geode Capital Management, LLC | 847,733 | $16.4M | 0.00% | +65,021+8.3% | Added |
| Wellington Management Group LLP | 859,102 | $16.6M | 0.00% | −151,606−15.0% | Reduced |
| Novo Holdings A/S | 911,111 | $17.6M | 1.10% | 00.0% | Unchanged |
| Redmile Group, LLC | 1,221,903 | $23.6M | 0.97% | −283,223−18.8% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 1,228,447 | $23.8M | 0.02% | +452,750+58.4% | Added |
| Nikko Asset Management Americas, Inc. | 1,228,447 | $23.8M | 0.34% | +452,750+58.4% | Added |
| Baker Bros. Advisors LP | 1,416,530 | $27.4M | 0.16% | 00.0% | Unchanged |
| Avidity Partners Management LP | 1,565,000 | $30.3M | 0.71% | +522,294+50.1% | Added |
| JPMorgan Chase & Co | 1,788,462 | $34.6M | 0.00% | −130,028−6.8% | Reduced |
| T. Rowe Price Investment Management, Inc. | 1,799,650 | $34.8M | 0.03% | +544,834+43.4% | Added |
| ARCH Venture Management, LLC | 2,008,809 | $38.9M | 9.96% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 2,078,289 | $40.2M | 0.11% | +328,552+18.8% | Added |
| Casdin Capital, LLC | 2,290,571 | $44.3M | 3.46% | −887,596−27.9% | Reduced |
| BlackRock Inc. | 3,594,074 | $69.5M | 0.00% | +217,864+6.5% | Added |
| Vanguard Group Inc | 3,812,024 | $73.8M | 0.00% | +153,212+4.2% | Added |
| ARK Investment Management LLCSuperinvestorARK Invest | 4,365,830 | $84.5M | 0.73% | +971,971+28.6% | Added |
| State Street Corp | 4,471,049 | $86.5M | 0.01% | +1,671,215+59.7% | Added |
| FMR LLC | 6,905,423 | $133.6M | 0.01% | −576,927−7.7% | Reduced |
| Alphabet Inc. | 10,549,086 | $204.1M | 11.86% | −424,925−3.9% | Reduced |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −775,000−100.0% | Sold out |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −750,000−100.0% | Sold out |
| M28 Capital Management LP | 0 | $0 | 0.00% | −87,600−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −45,394−100.0% | Sold out |
| EAM Global Investors LLC | 0 | $0 | 0.00% | −34,785−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −34,036−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −27,476−100.0% | Sold out |
| Temasek Holdings (Private) Ltd | 0 | $0 | 0.00% | −27,456−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −23,572−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −21,121−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −10,499−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Arizona State Retirement System | 0 | $0 | 0.00% | −8,746−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −7,254−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −7,100−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −7,062−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −6,280−100.0% | Sold out |
| Boston Private Wealth LLC | 0 | $0 | 0.00% | −6,025−100.0% | Sold out |
| SG3 Management, LLC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −52−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −38−100.0% | Sold out |
| Wit, LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Umb Bank N A | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Tilia Fiduciary Partners, Inc. | 0 | $0 | 0.00% | −14−100.0% | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |